Save time and get answers to complex questions with AI chat
What is dabrafenib mesylate msn patent issue?Guselkumab patent expiration?Norcuron generic name?Stribild expiry date?Pramlintide acetate price?
See the DrugPatentWatch profile for Toujeo
Toujeo (insulin glargine injection, 300 units/mL) received initial FDA approval in 2015 for once-daily insulin therapy. [1]
The initial FDA approval for Toujeo occurred in 2015, and the product labeling reflects that starting point. [1]
You can verify the precise approval timing and the relevant labeling language through the FDA’s drug listing/labeling records for Toujeo, which document the initial approval year (2015) and associated label information. [1] ---
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203314
Other Questions About Toujeo :